Reducing Cardiovascular Risk in Lupus Pregnancy: A Structured Multi-Phasic Management Model

Ali Muhammad  Murad; Manaf Jarallah Yaseen

doi:10.54133/ajms.v10i2.3017

Authors

Ali Muhammad Murad Department of Obstetrics and Gynecology, College of Medicine, Mustansiriyah University, Baghdad, Iraq
Manaf Jarallah Yaseen Department of Pediatrics, College of Medicine, University of Baghdad, Baghdad, Iraq https://orcid.org/0009-0000-3636-3514

DOI:

https://doi.org/10.54133/ajms.v10i2.3017

Keywords:

Cardiovascular risk, Lupus erythmatosus, Management model

Abstract

N/A

Downloads

Download data is not yet available.

References

Dhital R, Baer RJ, Kalunian K, Chambers C. Adverse pregnancy outcomes across SLE subgroups: significance of cardiovascular events. Lupus Sci Med. 2025;12(1). doi: 10.1136/lupus-2025-001507.

Choi MY, Guan H, Yoshida K, Paudel M, Kargere BA, Li D, et al. Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2024;67:152468. doi: 10.1016/j.semarthrit.2024.152468.

Zahid S, Mohamed MS, Wassif H, Nazir NT, Khan SS, Michos ED. Analysis of cardiovascular complications during delivery admissions among patients with systemic lupus erythematosus, 2004-2019. JAMA Netw Open. 2022;5(11):e2243388. doi: 10.1001/jamanetworkopen.2022.43388.

Nori W, Roomi AB, Akram W. Platelet indices as predictors of fetal growth restriction in Pre-eclamptic Women. Revista Latinoamericana de Hipertensión. 2020;15(4):280-285. doi: 10.5281/zenodo.4442971.

Du M, Zhang R, Na Y, Peng L, Bao S. Hydroxychloroquine therapy for women with both recurrent pregnancy loss and autoimmune disease: association with pregnancy outcomes and maternal-fetal complications. Front Immunol. 2026;17:1756063. doi: 10.3389/fimmu.2026.1756063.

De Backer J, Haugaa KH, Hasselberg NE, De Hosson M, Brida M, Castelletti S, et al. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy: Developed by the task force on the management of cardiovascular disease and pregnancy of the European Society of Cardiology (ESC) Endorsed by the European Society of Gynecology (ESG). Eur Heart J. 2025;46(43):4462-4568. doi: 10.1093/eurheartj/ehaf193.

Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15-29. doi: 10.1136/ard-2023-224762.

Nikuei P, Rajaei M, Roozbeh N, Mohseni F, Poordarvishi F, Azad M, et al. Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia. BMC Pregnancy Childbirth. 2020;20(1):80. doi: 10.1186/s12884-020-2744-2.

Yamazaki T, Cerdeira AS, Teraoka Y, Oomori Y, Mukai Y, Sugimoto J, et al. Predictive accuracy of sFlt-1/PlGF ratio for preeclampsia and adverse outcomes: prospective, multicenter including primary, secondary, and tertiary care institutions, observational study in Japan. Hypertens Res. 2025;48(10):2548-2557. doi: 10.1038/s41440-025-02282-0.

Yaseen MJ, Neamaa EK, Haji GF. Assessment of high risk pregnant women by fetal echocardiography. Al-Rafidain J Med Sci. 2024;7(2):157-162. doi: 10.54133/ajms.v7i2.1476.

Ali T, Khan M, Jarwar MA. Toward precision maternal care in systemic lupus erythematosus: bridging data limitations and research gaps. Clin Rheumatol. 2025;44(11):4773-4774. doi: 10.1007/s10067-025-07705-4.

Gamba A, Zen M, Depascale R, Calligaro A, Gatto M, Iaccarino L, et al. Modern management of pregnancy in systemic lupus erythematosus: from prenatal counseling to post-partum support. J Clin Med. 2024;13(12):3454. doi: 10.3390/jcm13123454.